Holen Sie sich die Stockscreener-App
69.45
1.77%
-1.25
Handel nachbörslich:
69.45
Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten
Will PTC Therapeutics Inc. benefit from current market trendsMarket Movement Recap & Short-Term High Return Ideas - mfd.ru
PTC Withdraws Translarna US FDA Filing - Citeline News & Insights
PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug - MedCity News
PTC Withdraws FDA Filing For Translarna - Citeline News & Insights
PTC Therapeutics withdraws Translarna NDA - The Pharma Letter
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof - Benzinga
PTC Therapeutics Withdraws NDA Resubmission for Translarna Following FDA Feedback - marketscreener.com
PTC Therapeutics Withdraws Translarna NDA After FDA Feedback - TipRanks
PTC Therapeutics falls after withdrawing muscle disorder drug marketing application - TradingView
PTC Therapeutics stock falls after withdrawing Translarna drug application By Investing.com - Investing.com Canada
PTC Therapeutics Provides Regulatory Update on Translarna™ - Yahoo Finance
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Finviz
PTC Therapeutics (PTCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Shareholders Have Earned a 18% CAGR Over the Last Three Years - 富途牛牛
PTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKU - MSN
Price Action: How does Guardian Pharmacy Services Inc correlate with NasdaqTrade Risk Assessment & Safe Entry Point Alerts - baoquankhu1.vn
PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation - ChartMill
PTC Therapeutics, Inc. $PTCT Stock Position Decreased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Johnson & Johnson vs PTC Therapeutics: Which Stock Could Rally? - Trefis
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 - Finviz
Between PTC Therapeutics and Eli Lilly, Which Stock Looks Set to Break Out? - Trefis
PTC Therapeutics vs Merck: Which Is the Stronger Buy Today? - Trefis
Understanding Momentum Shifts in (PTCT) - Stock Traders Daily
Tech Rally: Is PTC Therapeutics Inc a stock for growth or value investorsJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
WCM Investment Management LLC Acquires Shares of 147,065 PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (PTCT) Investor Outlook: An 18% Upside Potential Amidst Robust Pipeline - DirectorsTalk Interviews
PTCT SEC FilingsPtc Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup - ChartMill
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Meme Stocks: What is PTC Therapeutics Inc.’s book value per shareEarnings Overview Summary & Growth Focused Entry Reports - baoquankhu1.vn
Evaluating PTC Therapeutics (PTCT) Valuation After Barclays Rating Upgrade And Growing Analyst Confidence - Yahoo Finance
Converging Analyst Upgrades on PTC’s Rare Disease Pipeline Might Change The Case For Investing In PTC Therapeutics (PTCT) - Sahm
Barclays Upgrades PTC Therapeutics (PTCT) - Nasdaq
PTC Therapeutics (PTCT) Sees Analyst Rating Upgrade to Overweigh - GuruFocus
PTC Therapeutics stock initiated with Overweight rating at Barclays By Investing.com - Investing.com Canada
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Potential Upside with Innovative Rare Disorder Treatments - DirectorsTalk Interviews
A Look At PTC Therapeutics (PTCT) Valuation After New 2026 Revenue Guidance And Morgan Stanley Support - Sahm
Sector Gamma AS Increases Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Avoiding Lag: Real-Time Signals in (PTCT) Movement - Stock Traders Daily
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves - Finviz
QRG Capital Management Inc. Takes Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Momentum Shift: What is International Money Express Incs market positionTrade Exit Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
First Week of September 18th Options Trading For PTC Therapeutics - Nasdaq
Does 2026 Revenue Guidance And Sephience Momentum Change The Bull Case For PTC Therapeutics (PTCT)? - Sahm
Discipline and Rules-Based Execution in PTCT Response - Stock Traders Daily
PTC Therapeutics projects FY26 product revenue between $700M to $800M - MSN
PTC Therapeutics reports $92.5M in Q4 Sephience revenue By Investing.com - Investing.com Nigeria
Lobbying Update: $50,000 of PTC THERAPEUTICS INC. lobbying was just disclosed - Quiver Quantitative
Ptc Therapeutics CEO Klein sells $192k in shares By Investing.com - Investing.com Nigeria
Ptc Therapeutics CEO Klein sells $192k in shares - Investing.com
Utter, SVP at Ptc Therapeutics, sells $79k in shares By Investing.com - Investing.com Canada
Pauwels Eric, chief business officer of Ptc Therapeutics, sells $566k in shares - Investing.com Canada
PTC Therapeutics (NASDAQ:PTCT) VP Sells $180,330.02 in Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 4,602 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 881 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) EVP Lee Scott Golden Sells 866 Shares - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CEO Sells $192,195.30 in Stock - MarketBeat
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):